Gulimila A bu dou re xi ti

An open-label evaluation of safety and tolerability of coformulated bictegravir/emtricitabine/tenofovir alafenamide for post-exposure prophylaxis following potential exposure to human immunodeficiency virus-1

R. Xin, Lijun Sun, Lili Dai, 2022, Chinese medical journal.